These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
||||||||||
|
|
|
||||||||||
|
|
|
|
|||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
x | Accelerated filer | o | ||||||||
| Non-accelerated filer |
o
|
Smaller reporting company
|
|
||||||||
| Emerging growth company |
|
||||||||||
| TABLE OF CONTENTS | ||||||||
|
Form 10-Q
Cross Reference
|
Page
|
|||||||
| Part I, Item 1. | ||||||||
| Part I, Item 2. | ||||||||
| Part I, Item 3. | ||||||||
| Part I, Item 4. | ||||||||
| Part II, Item 1. | ||||||||
|
Risk Factors
|
Part II, Item 1A. | |||||||
| Part II, Item 2. | ||||||||
| Part II, Item 3. | ||||||||
| Part II, Item 4. | ||||||||
| Part II, Item 5. | ||||||||
| Part II, Item 6. | ||||||||
| GLOSSARY | |||||
| 2021 Credit Program | A program that, subject to certain predefined conditions, is designed to take certain pandemic related excess health care cost savings and provide credits to certain 2021 customers. | ||||
| 2018 Term Loan | Our $425 million term loan A that we entered into in June 2018 | ||||
| AFS | Available-for-sale | ||||
| CARES Act | Coronavirus Aid Relief and Economic Security Act | ||||
| CEO | Chief Executive Officer | ||||
| CFO | Chief Financial Officer | ||||
| COBRA | Consolidated Omnibus Budget Reconciliation Act | ||||
| COPS | Cost of providing services | ||||
| COVID-19 | Novel coronavirus | ||||
| D&A | Depreciation and amortization expenses | ||||
| EBITDA | Earnings before interest expense, taxes, depreciation and amortization of intangible assets | ||||
| EPS | Earnings Per Share | ||||
| ERISA | Employee Retirement Income Security Act | ||||
| ESAC | Employer Services Assurance Corporation | ||||
| ETR | Effective tax rate | ||||
| FFCRA | Families First Coronavirus Response Act | ||||
| G&A | General and administrative | ||||
| GAAP | Generally Accepted Accounting Principles in the United States | ||||
| HR | Human Resources | ||||
| IRS | Internal Revenue Service | ||||
| ISR | Insurance service revenues | ||||
| LIBOR | London Inter-bank Offered Rate | ||||
| MD&A | Management's Discussion and Analysis of Financial Condition and Results of Operations | ||||
| NIM | Net Insurance Margin | ||||
| NISR | Net Insurance Service Revenues | ||||
| NSR | Net service revenues | ||||
| OE | Operating expenses | ||||
| PEO | Professional Employer Organization | ||||
| PFC | Payroll funds collected | ||||
| PPP | Paycheck Protection Program, a loan program administered by the U.S. Small Business Administration | ||||
| PSR | Professional service revenues | ||||
| Recovery Credit | Program to provide clients with one-time reductions against fees for future services | ||||
| Reg FD | Regulation Fair Disclosure | ||||
| ROU | Right-of-use | ||||
| RSA | Restricted Stock Award | ||||
| RSU | Restricted Stock Unit | ||||
| SBC | Stock Based Compensation | ||||
| S&M | Sales and marketing | ||||
| S&P | Standard & Poor's | ||||
| SD&P | Systems development and programming | ||||
| SEC | U.S. Securities and Exchange Commission | ||||
| SMB | Small and medium-size business | ||||
| U.S. | United States | ||||
| WSE | Worksite employee | ||||
| YTD | Year to date | ||||
| FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION | |||||
| FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION | |||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| $1.1B | $138M | $309M | ||||||||||||||||||||||||
| Total revenues | Operating income | Net Service Revenues * | ||||||||||||||||||||||||
| 1 | % | increase | 15 | % | increase | 9 | % | increase | ||||||||||||||||||
| $101M | $1.51 | $111M | ||||||||||||||||||||||||
| Net income | Diluted EPS | Adjusted Net income * | ||||||||||||||||||||||||
| 11 | % | increase | 15 | % | increase | 14 | % | increase | ||||||||||||||||||
| * |
Non-GAAP measure. See definitions below under the heading "
Non-GAAP Financial Measures
".
|
|||||||||||||||||||||||||
| 321,295 | 326,216 | ||||||||||||||||
| Average WSEs | Total WSEs | ||||||||||||||||
| (4) | % | decrease | (3) | % | decrease | ||||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | |||||||||||
| (in millions, except operating metrics data) | 2021 | 2020 | % Change | ||||||||
| Income Statement Data: | |||||||||||
| Professional service revenues | $ | 153 | $ | 156 | (2) | % | |||||
| Insurance service revenues | 907 | 892 | 2 | ||||||||
| Total revenues | 1,060 | 1,048 | 1 | ||||||||
| Insurance costs | 751 | 765 | (2) | ||||||||
| Operating expenses | 171 | 163 | 5 | ||||||||
| Total costs and operating expenses | 922 | 928 | (1) | ||||||||
| Operating income | 138 | 120 | 15 | ||||||||
| Other income (expense): | |||||||||||
| Interest expense, bank fees and other | (5) | (4) | 25 | ||||||||
| Interest income | 2 | 5 | (60) | ||||||||
| Income before provision for income taxes | 135 | 121 | 12 | ||||||||
| Income taxes | 34 | 30 | 13 | ||||||||
| Net income | $ | 101 | $ | 91 | 11 | % | |||||
| Cash Flow Data: | |||||||||||
| Net cash used in operating activities | (175) | $ | (282) | (38) | |||||||
| Net cash used in investing activities | (3) | (94) | (97) | ||||||||
| Net cash provided by financing activities | 56 | 185 | (70) | ||||||||
|
Non-GAAP measures
(1)
:
|
|||||||||||
| Net Service Revenues | $ | 309 | $ | 283 | 9 | % | |||||
| Net Insurance Service Revenues | $ | 156 | $ | 127 | 23 | ||||||
| Net Insurance Margin | 17 | % | 14 | % | 2 | ||||||
| Adjusted EBITDA | 163 | 145 | 12 | ||||||||
| Adjusted Net income | 111 | 97 | 14 | ||||||||
| Corporate Operating Cash Flows | 131 | 119 | 10 | ||||||||
| Operating Metrics: | |||||||||||
| Average WSEs | 321,295 | 336,348 | (4) | % | |||||||
| Total WSEs | 326,216 | 336,846 | (3) | ||||||||
| (in millions) |
March 31,
2021 |
December 31,
2020 |
% Change | |||||||||||||||||
| Balance Sheet Data: | ||||||||||||||||||||
| Working capital | $ | 520 | $ | 290 | 79 | % | ||||||||||||||
| Total assets | 3,005 | 3,043 | (1) | |||||||||||||||||
| Debt | 494 | 370 | 34 | |||||||||||||||||
| Total stockholders’ equity | 653 | 607 | 8 | |||||||||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Non-GAAP Measure | Definition |
How We Use The Measure
|
||||||
|
Net Service Revenues
|
• Sum of professional service revenues and Net Insurance Service Revenues,
or total revenues less insurance costs. |
• Provides a comparable basis of revenues on a net basis. Professional service revenues are presented net of client payroll costs whereas insurance service revenues are presented gross of insurance costs for financial reporting purposes.
• Acts as the basis to allocate resources to different functions and evaluates the effectiveness of our business strategies by each business function.
• Provides a measure, among others, used in the determination of incentive compensation for management.
|
||||||
|
Net Insurance Service Revenues
|
• Insurance service revenues less insurance costs.
|
• Is a component of Net Service Revenues.
• Provides a comparable basis of revenues on a net basis. Professional service revenues are presented net of client payroll costs whereas insurance service revenues are presented gross of insurance costs for financial reporting purposes. Promotes an understanding of our insurance services business by evaluating insurance service revenues net of our WSE related costs which are substantially pass-through for the benefit of our WSEs. Under GAAP, insurance service revenues and costs are recorded gross as we have latitude in establishing the price, service and supplier specifications.
|
||||||
|
Net Insurance Margin
|
• Net Insurance Margin (NIM) is the ratio of Net Insurance Services Revenues to insurance service revenues.
|
• Provides a comparable basis of Net Insurance Service Revenues relative to insurance service revenues. Promotes an understanding of our pricing to risk performance. | ||||||
|
Adjusted EBITDA
|
• Net income, excluding the effects of:
- income tax provision,
- interest expense, bank fees and other,
- depreciation,
- amortization of intangible assets, and
- stock based compensation expense.
|
• Provides period-to-period comparisons on a consistent basis and an understanding as to how our management evaluates the effectiveness of our business strategies by excluding certain non-cash charges such as depreciation and amortization, and stock-based compensation recognized based on the estimated fair values. We believe these charges are either not directly resulting from our core operations or not indicative of our ongoing operations.
• Enhances comparisons to prior periods and, accordingly, facilitates the development of future projections and earnings growth prospects.
• Provides a measure, among others, used in the determination of incentive compensation for management.
• We also sometimes refer to Adjusted EBITDA margin, which is the ratio of Adjusted EBITDA to Net Service Revenue.
|
||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
|
Adjusted Net Income
|
• Net income, excluding the effects of:
- effective income tax rate
(1)
,
- stock based compensation,
- amortization of intangible assets,
- non-cash interest expense
(2)
, and
- the income tax effect (at our effective tax rate
(1)
of these pre-tax adjustments.
|
• Provides information to our stockholders and board of directors to understand how our management evaluates our business, to monitor and evaluate our operating results, and analyze profitability of our ongoing operations and trends on a consistent basis by excluding certain non-cash charges.
|
||||||
| Corporate Operating Cash Flows |
• Net cash provided by (used in) operating activities, excluding the effects of:
- Assets associated with WSEs (accounts receivable, unbilled revenue, prepaid expenses and other current assets) and - Liabilities associated with WSEs (client deposits and other client liabilities, accrued wages, payroll tax liabilities and other payroll withholdings, accrued health benefit costs, accrued workers' compensation costs, insurance premiums and other payables, and other current liabilities). |
• Provides information that our stockholders and management can use to evaluate our cash flows from operations independent of the current assets and liabilities associated with our WSEs.
• Enhances comparisons to prior periods and, accordingly, used as a liquidity measure to manage liquidity between corporate and WSE related activities, and to help determine and plan our cash flow and capital strategies.
|
||||||
| Three Months Ended March 31, | |||||||||||||||||
|
(in millions)
|
2021 | 2020 | |||||||||||||||
|
Total revenues
|
$ | 1,060 | $ | 1,048 | |||||||||||||
|
Less: Insurance costs
|
751 | 765 | |||||||||||||||
|
Net Service Revenues
|
$ | 309 | $ | 283 | |||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
|
(in millions)
|
2021 | 2020 | |||||||||||||||
|
Insurance service revenues
|
$ | 907 | $ | 892 | |||||||||||||
|
Less: Insurance costs
|
751 | 765 | |||||||||||||||
|
Net Insurance Service Revenues
|
$ | 156 | $ | 127 | |||||||||||||
| Net Insurance Margin | 17 | % | 14 | % | |||||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | |||||||||||||||||
|
(in millions)
|
2021 | 2020 | |||||||||||||||
|
Net income
|
$ | 101 | $ | 91 | |||||||||||||
|
Provision for income taxes
|
34 | 30 | |||||||||||||||
|
Stock based compensation
|
11 | 9 | |||||||||||||||
| Interest expense, bank fees and other | 5 | 4 | |||||||||||||||
|
Depreciation and amortization of intangible assets
|
12 | 11 | |||||||||||||||
|
Adjusted EBITDA
|
$ | 163 | $ | 145 | |||||||||||||
|
Adjusted EBITDA Margin
|
53 | % | 51 | % | |||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
|
(in millions)
|
2021 | 2020 | |||||||||||||||
|
Net income
|
$ | 101 | $ | 91 | |||||||||||||
| Effective income tax rate adjustment | — | (1) | |||||||||||||||
| Stock based compensation | 11 | 9 | |||||||||||||||
| Amortization of intangible assets | 1 | 1 | |||||||||||||||
| Non-cash interest expense | 2 | — | |||||||||||||||
| Income tax impact of pre-tax adjustments | (4) | (3) | |||||||||||||||
| Adjusted Net Income | $ | 111 | $ | 97 | |||||||||||||
|
Three Months Ended
March 31, |
||||||||
|
(in millions)
|
2021 | 2020 | ||||||
| Net cash used in operating activities | $ | (175) | $ | (282) | ||||
| Less: Change in WSE related other current assets | (85) | (110) | ||||||
| Less: Change in WSE related liabilities | (221) | (291) | ||||||
| Net cash used in operating activities - WSE | $ | (306) | $ | (401) | ||||
| Net cash provided by operating activities - Corporate | $ | 131 | $ | 119 | ||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| PSR | ||||||||||||||
| ISR - % represents proportion of ISR to total revenues | ||||||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| (in millions) | |||||||||||
| $120 | First Quarter 2020 Operating Income | ||||||||||
| +12 |
Higher total revenues, primarily as a result of increased health plan enrollment in our insurance service offerings, together with rate increases, partially offset by lower Average WSEs, the $12 million reduction recognized under our Recovery Credit and the $25 million reduction recognized under our 2021 Credit Program.
|
||||||||||
| +14 |
Lower insurance costs primarily as a result of
lower utilization of medical services and lower Average WSEs, partially offset by higher health plan enrollments.
|
||||||||||
| -8 | Higher OE primarily as a result of increased compensation to support initiatives to improve client experience, enhance service offerings, and improve processes. | ||||||||||
| $138 | First Quarter 2021 Operating Income | ||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| PSR | ||||||||
| Net insurance service revenues - % represents proportion of Net Insurance Service Revenues to total Net Service Revenues | ||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| % represents portion of compensation related expense included in operating expenses | |||||||||||||||||||||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| (in millions) | |||||||||||
| $163 | Q1 2020 Operating Expenses | ||||||||||
| +3 | G&A increased, driven primarily by increases in compensation related expenses. | ||||||||||
| +4 | SD&P increased, driven primarily by higher consulting expenses as we continue to work to improve our client experience and our systems and processes. | ||||||||||
| +1 | D&A remained consistent to the first quarter of 2020. | ||||||||||
| $171 | Q1 2021 Operating Expenses | ||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||
| (in millions) | Corporate | WSE | Total | Corporate | WSE | Total | |||||||||||||||||
| Current assets: | |||||||||||||||||||||||
| Cash and cash equivalents | $ | 500 | $ | — | $ | 500 | $ | 301 | $ | — | $ | 301 | |||||||||||
| Investments | 71 | — | 71 | 57 | — | 57 | |||||||||||||||||
| Restricted cash, cash equivalents and investments | 15 | 1,066 | 1,081 | 15 | 1,373 | 1,388 | |||||||||||||||||
| Other current assets | 68 | 440 | 508 | 59 | 355 | 414 | |||||||||||||||||
| Total current assets | $ | 654 | $ | 1,506 | $ | 2,160 | $ | 432 | $ | 1,728 | $ | 2,160 | |||||||||||
| Total current liabilities | $ | 134 | $ | 1,506 | $ | 1,640 | $ | 142 | $ | 1,728 | $ | 1,870 | |||||||||||
| Working capital | $ | 520 | $ | — | $ | 520 | $ | 290 | $ | — | $ | 290 | |||||||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | |||||||||||||||||||||||
|
(in millions)
|
2021 | 2020 | |||||||||||||||||||||
| Corporate | WSE | Total | Corporate | WSE | Total | ||||||||||||||||||
|
Net cash provided by (used in):
|
|||||||||||||||||||||||
|
Operating activities
|
$ | 131 | $ | (306) | $ | (175) | $ | 119 | $ | (401) | $ | (282) | |||||||||||
|
Investing activities
|
6 | (9) | (3) | (19) | (75) | (94) | |||||||||||||||||
|
Financing activities
|
56 | — | 56 | 185 | — | 185 | |||||||||||||||||
|
Net increase (decrease) in cash and cash equivalents, unrestricted and restricted
|
$ | 193 | $ | (315) | $ | (122) | $ | 285 | $ | (476) | $ | (191) | |||||||||||
|
Cash and cash equivalents, unrestricted and restricted:
|
|||||||||||||||||||||||
|
Beginning of period
|
352 | 1,291 | 1,643 | 291 | 1,165 | 1,456 | |||||||||||||||||
|
End of period
|
$ | 545 | $ | 976 | $ | 1,521 | $ | 576 | $ | 689 | $ | 1,265 | |||||||||||
|
Net increase (decrease) in cash and cash equivalents:
|
|||||||||||||||||||||||
|
Unrestricted
|
$ | 199 | $ | — | $ | 199 | $ | 308 | $ | — | $ | 308 | |||||||||||
|
Restricted
|
(6) | (315) | (321) | (23) | (476) | (499) | |||||||||||||||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2021 | 2020 | ||||||
| Net cash used in operating activities | $ | (175) | $ | (282) | ||||
| Net cash used in operating activities - WSE | (306) | $ | (401) | |||||
| Net cash provided by operating activities - Corporate | 131 | 119 | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2021 | 2020 | ||||||
| Investments: | ||||||||
| Purchases of investments | (82) | (155) | ||||||
| Proceeds from sale and maturity of investments | 84 | 67 | ||||||
| Cash provided by (used in) investments | $ | 2 | $ | (88) | ||||
| Capital expenditures: | ||||||||
| Software and hardware | $ | (4) | $ | (6) | ||||
| Office furniture, equipment and leasehold improvements | (1) | — | ||||||
| Cash used in capital expenditures | $ | (5) | $ | (6) | ||||
| Cash used in investing activities | $ | (3) | $ | (94) | ||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2021 | 2020 | ||||||
| Financing activities | ||||||||
| Repurchase of common stock, net of issuance | $ | (65) | $ | (43) | ||||
|
Draw down from revolving credit facility
|
— | 234 | ||||||
| Payment of long-term financing fees | (2) | — | ||||||
| Payment of debt issuance costs | (7) | — | ||||||
| Proceeds from issuance of 2029 Notes | 500 | — | ||||||
| Repayment of borrowings | (370) | (6) | ||||||
| Cash provided by financing activities | $ | 56 | $ | 185 | ||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
AND CONTROLS AND PROCEDURES
|
|||||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
AND CONTROLS AND PROCEDURES
|
|||||
| FINANCIAL STATEMENTS | |||||
| Three Months Ended March 31, | |||||||||||||||||
| (in millions except per share data) | 2021 | 2020 | |||||||||||||||
|
Professional service revenues
|
$ |
|
$ |
|
|||||||||||||
|
Insurance service revenues
|
|
|
|||||||||||||||
|
Total revenues
|
|
|
|||||||||||||||
|
Insurance costs
|
|
|
|||||||||||||||
|
Cost of providing services
|
|
|
|||||||||||||||
|
Sales and marketing
|
|
|
|||||||||||||||
|
General and administrative
|
|
|
|||||||||||||||
|
Systems development and programming
|
|
|
|||||||||||||||
|
Depreciation and amortization of intangible assets
|
|
|
|||||||||||||||
|
Total costs and operating expenses
|
|
|
|||||||||||||||
|
Operating income
|
|
|
|||||||||||||||
|
Other income (expense):
|
|||||||||||||||||
|
Interest expense, bank fees and other
|
(
|
(
|
|||||||||||||||
|
Interest income
|
|
|
|||||||||||||||
|
Income before provision for income taxes
|
|
|
|||||||||||||||
|
Income taxes
|
|
|
|||||||||||||||
|
Net income
|
$ |
|
$ |
|
|||||||||||||
| Other comprehensive (loss) income, net of income taxes |
(
|
|
|||||||||||||||
|
Comprehensive income
|
$ |
|
$ |
|
|||||||||||||
|
Net income per share:
|
|||||||||||||||||
|
Basic
|
$ |
|
$ |
|
|||||||||||||
|
Diluted
|
$ |
|
$ |
|
|||||||||||||
|
Weighted average shares:
|
|||||||||||||||||
|
Basic
|
|
|
|||||||||||||||
|
Diluted
|
|
|
|||||||||||||||
| FINANCIAL STATEMENTS | |||||
| March 31, | December 31, | |||||||||||||
| (in millions, except share and per share data) | 2021 | 2020 | ||||||||||||
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
|
Cash and cash equivalents
|
$ |
|
$ |
|
||||||||||
|
Investments
|
|
|
||||||||||||
|
Restricted cash, cash equivalents and investments
|
|
|
||||||||||||
|
Accounts receivable, net
|
|
|
||||||||||||
|
Unbilled revenue, net
|
|
|
||||||||||||
|
Prepaid expenses, net
|
|
|
||||||||||||
|
Other current assets
|
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
|
Restricted cash, cash equivalents and investments, noncurrent
|
|
|
||||||||||||
|
Investments, noncurrent
|
|
|
||||||||||||
|
Property, equipment and software, net
|
|
|
||||||||||||
|
Operating lease right-of-use asset
|
|
|
||||||||||||
|
Goodwill
|
|
|
||||||||||||
|
Other intangible assets, net
|
|
|
||||||||||||
|
Other assets
|
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities and stockholders' equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
|
Accounts payable and other current liabilities
|
$ |
|
$ |
|
||||||||||
|
Long-term debt
|
|
|
||||||||||||
|
Client deposits and other client liabilities
|
|
|
||||||||||||
|
Accrued wages
|
|
|
||||||||||||
|
Accrued health insurance costs, net
|
|
|
||||||||||||
|
Accrued workers' compensation costs, net
|
|
|
||||||||||||
|
Payroll tax liabilities and other payroll withholdings
|
|
|
||||||||||||
|
Operating lease liabilities
|
|
|
||||||||||||
|
Insurance premiums and other payables
|
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
|
Long-term debt, noncurrent
|
|
|
||||||||||||
|
Accrued workers' compensation costs, noncurrent, net
|
|
|
||||||||||||
|
Deferred taxes
|
|
|
||||||||||||
|
Operating lease liabilities, noncurrent
|
|
|
||||||||||||
|
Other non-current liabilities
|
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
| Commitments and contingencies (see Note 7) |
|
|
||||||||||||
| Stockholders' equity: | ||||||||||||||
| Preferred stock |
|
|
||||||||||||
|
($
|
||||||||||||||
| Common stock and additional paid-in capital |
|
|
||||||||||||
|
($
|
||||||||||||||
| Accumulated deficit |
(
|
(
|
||||||||||||
|
Accumulated other comprehensive income
|
|
|
||||||||||||
| Total stockholders' equity |
|
|
||||||||||||
| Total liabilities & stockholders' equity | $ |
|
$ |
|
||||||||||
| FINANCIAL STATEMENTS | |||||
| Three Months Ended March 31, | |||||||||||||||||
|
(in millions)
|
2021 | 2020 | |||||||||||||||
| Total Stockholders' Equity, beginning balance | $ |
|
$ |
|
|||||||||||||
| Common Stock and Additional Paid-In Capital | |||||||||||||||||
|
Beginning balance
|
|
|
|||||||||||||||
|
Stock based compensation expense
|
|
|
|||||||||||||||
|
Ending balance
|
|
|
|||||||||||||||
|
Accumulated Deficit
|
|||||||||||||||||
|
Beginning balance
|
(
|
(
|
|||||||||||||||
|
Net income
|
|
|
|||||||||||||||
|
Repurchase of common stock
|
(
|
(
|
|||||||||||||||
|
Awards effectively repurchased for required employee withholding taxes
|
(
|
(
|
|||||||||||||||
|
Ending balance
|
(
|
(
|
|||||||||||||||
| Accumulated Other Comprehensive Income | |||||||||||||||||
|
Beginning balance
|
|
|
|||||||||||||||
| Other comprehensive (loss) income |
(
|
|
|||||||||||||||
|
Ending balance
|
|
|
|||||||||||||||
|
Total Stockholders' Equity, ending balance
|
$ |
|
$ |
|
|||||||||||||
| FINANCIAL STATEMENTS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2021 | 2020 | ||||||
|
Operating activities
|
||||||||
|
Net income
|
$ |
|
$ |
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
Amortization of ROU
|
|
|
||||||
|
Accretion of discount rate on lease liabilities
|
|
|
||||||
| Amortization of premium of investments |
|
|
||||||
|
Stock based compensation
|
|
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable, net
|
|
|
||||||
|
Unbilled revenue, net
|
(
|
(
|
||||||
|
Prepaid expenses, net
|
|
(
|
||||||
|
Accounts payable and other current liabilities
|
|
|
||||||
|
Client deposits and other client liabilities
|
|
(
|
||||||
|
Accrued wages
|
|
|
||||||
|
Accrued health insurance costs, net
|
(
|
(
|
||||||
|
Accrued workers' compensation costs, net
|
|
|
||||||
|
Payroll taxes payable and other payroll withholdings
|
(
|
(
|
||||||
|
Operating lease liabilities
|
(
|
(
|
||||||
|
Other assets
|
(
|
(
|
||||||
|
Other liabilities
|
(
|
|
||||||
| Net cash used in operating activities |
(
|
(
|
||||||
|
Investing activities
|
||||||||
|
Purchases of marketable securities
|
(
|
(
|
||||||
| Proceeds from sale and maturity of marketable securities |
|
|
||||||
|
Acquisitions of property and equipment
|
(
|
(
|
||||||
|
Net cash used in investing activities
|
(
|
(
|
||||||
|
Financing activities
|
||||||||
|
Repurchase of common stock
|
(
|
(
|
||||||
|
Awards effectively repurchased for required employee withholding taxes
|
(
|
(
|
||||||
|
Proceeds from revolving credit agreement borrowings
|
|
|
||||||
| Payment of long-term financing fees |
(
|
|
||||||
| Payment of debt issuance costs |
(
|
|
||||||
| Proceeds from issuance of 2029 Notes |
|
|
||||||
|
Repayment of debt
|
(
|
(
|
||||||
| Net cash provided by financing activities |
|
|
||||||
| Net decrease in cash and cash equivalents, unrestricted and restricted |
(
|
(
|
||||||
|
Cash and cash equivalents, unrestricted and restricted:
|
||||||||
|
Beginning of period
|
|
|
||||||
|
End of period
|
$ |
|
$ |
|
||||
|
Supplemental disclosures of cash flow information
|
||||||||
|
Interest paid
|
$ |
|
$ |
|
||||
|
Income taxes paid, net
|
|
|
||||||
|
Supplemental schedule of noncash investing and financing activities
|
||||||||
|
Payable for purchase of property and equipment
|
$ |
|
$ |
|
||||
| FINANCIAL STATEMENTS | |||||
| FINANCIAL STATEMENTS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2021 | |||||||
| Balance at beginning of period | $ |
|
||||||
| (+) Accruals |
|
|||||||
| (-) Distributions to clients |
(
|
|||||||
| Balance at end of period | $ |
|
||||||
| FINANCIAL STATEMENTS | |||||
| March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||
| (in millions) | Cash and cash equivalents | Available-for-sale marketable securities | Total | Cash and cash equivalents | Available-for-sale marketable securities | Total | |||||||||||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| Investments |
|
|
|
|
|
|
|||||||||||||||||||||||
| Restricted cash, cash equivalents and investments: | |||||||||||||||||||||||||||||
| Payroll funds collected |
|
|
|
|
|
|
|||||||||||||||||||||||
| Collateral for health benefits claims |
|
|
|
|
|
|
|||||||||||||||||||||||
|
Collateral for workers' compensation claims
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Other security deposits |
|
|
|
|
|
|
|||||||||||||||||||||||
|
Total restricted cash, cash equivalents and investments
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Investments, noncurrent |
|
|
|
|
|
|
|||||||||||||||||||||||
| Restricted cash, cash equivalents and investments, noncurrent | |||||||||||||||||||||||||||||
| Collateral for workers' compensation claims |
|
|
|
|
|
|
|||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||
| (in millions) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||
| Asset-backed securities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||
| Corporate bonds |
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
U.S. government agencies and government-
sponsored agencies
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| U.S. treasuries |
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Certificate of deposit |
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Other debt securities |
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||
| FINANCIAL STATEMENTS | |||||
| (in millions) | March 31, 2021 | ||||||||||
| One year or less | $ |
|
|||||||||
| Over one year through five years |
|
||||||||||
| Over five years through ten years |
|
||||||||||
| Over ten years |
|
||||||||||
| Total fair value | $ |
|
|||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2021 | 2020 | |||||||||||||||
| Gross proceeds from sales | $ |
|
$ |
|
|||||||||||||
| Gross proceeds from maturities |
|
|
|||||||||||||||
| Total | $ |
|
$ |
|
|||||||||||||
| FINANCIAL STATEMENTS | |||||
| (in millions) |
Level 1
|
Level 2
|
Total
|
||||||||
| March 31, 2021 | |||||||||||
|
Cash equivalents:
|
|||||||||||
|
Money market mutual funds
|
$ |
|
$ |
|
|
||||||
|
Total cash equivalents
|
|
|
|
||||||||
|
Investments:
|
|||||||||||
|
Asset-backed securities
|
|
|
|
||||||||
|
Corporate bonds
|
|
|
|
||||||||
|
U.S. government agencies and government-sponsored agencies
|
|
|
|
||||||||
|
U.S. treasuries
|
|
|
|
||||||||
|
Other debt securities
|
|
|
|
||||||||
|
Total investments
|
|
|
|
||||||||
|
Restricted cash equivalents:
|
|||||||||||
|
Money market mutual funds
|
|
|
|
||||||||
| Certificate of deposit |
|
|
|
||||||||
|
Commercial paper
|
|
|
|
||||||||
|
Total restricted cash equivalents
|
|
|
|
||||||||
|
Restricted investments:
|
|||||||||||
| Corporate bonds |
|
|
|
||||||||
| U.S. government agencies and government-sponsored agencies |
|
|
|
||||||||
| U.S. treasuries |
|
|
|
||||||||
|
Certificate of deposit
|
|
|
|
||||||||
|
Total restricted investments
|
|
|
|
||||||||
| Total cash equivalents and investments and restricted cash equivalents and investments | $ |
|
$ |
|
$ |
|
|||||
| (in millions) | Level 1 | Level 2 | Total | ||||||||
| December 31, 2020 | |||||||||||
| Cash equivalents | |||||||||||
| Money market mutual funds | $ |
|
$ |
|
$ |
|
|||||
| U.S. treasuries |
|
|
|
||||||||
| Total cash equivalents |
|
|
|
||||||||
| Investments | |||||||||||
| Asset-backed securities |
|
|
|
||||||||
| Corporate bonds |
|
|
|
||||||||
| U.S. government agencies and government-sponsored agencies |
|
|
|
||||||||
| U.S. treasuries |
|
|
|
||||||||
| Other debt securities |
|
|
|
||||||||
| Total investments |
|
|
|
||||||||
| Restricted cash equivalents: | |||||||||||
| Money market mutual funds |
|
|
|
||||||||
| Total restricted cash equivalents |
|
|
|
||||||||
| Restricted investments: | |||||||||||
| Corporate bonds |
|
|
|
||||||||
| U.S. government agencies and government-sponsored agencies |
|
|
|
||||||||
| U.S. treasuries |
|
|
|
||||||||
| Total restricted investments |
|
|
|
||||||||
| Total investments and restricted cash equivalents and investments | $ |
|
$ |
|
$ |
|
|||||
| FINANCIAL STATEMENTS | |||||
|
Three Months Ended
March 31, |
|||||||||||||||||
| (in millions) | 2021 | 2020 | |||||||||||||||
| Total accrued costs, beginning of period | $ |
|
$ |
|
|||||||||||||
| Incurred | |||||||||||||||||
| Current year |
|
|
|||||||||||||||
| Prior years |
(
|
(
|
|||||||||||||||
| Total incurred |
|
|
|||||||||||||||
| Paid | |||||||||||||||||
| Current year |
(
|
(
|
|||||||||||||||
| Prior years |
(
|
(
|
|||||||||||||||
| Total paid |
(
|
(
|
|||||||||||||||
| Total accrued costs, end of period | $ |
|
$ |
|
|||||||||||||
| (in millions) | March 31, 2021 | December 31, 2020 | ||||||
| Total accrued costs, end of period | $ |
|
$ |
|
||||
| Collateral paid to carriers and offset against accrued costs |
(
|
(
|
||||||
| Total accrued costs, net of carrier collateral offset | $ |
|
$ |
|
||||
|
Payable in less than 1 year
(net of collateral paid to carriers of $ |
$ |
|
$ |
|
||||
|
Payable in more than 1 year
(net of collateral paid to carriers of $ |
|
|
||||||
| Total accrued costs, net of carrier collateral offset | $ |
|
$ |
|
||||
| FINANCIAL STATEMENTS | |||||
| (in millions) | March 31, 2021 | December 31, 2020 | ||||||
| 2018 Term Loan A | $ |
|
$ |
|
||||
| 2029 Notes |
|
|
||||||
| Principal amount |
|
|
||||||
| Deferred issuance costs |
(
|
|
||||||
| Less: current portion |
|
(
|
||||||
| Long-term debt, noncurrent | $ |
|
$ |
|
||||
| Annual contractual interest rate |
|
% |
|
% | ||||
| Effective interest rate |
|
% |
|
% | ||||
| FINANCIAL STATEMENTS | |||||
|
Total Number
of RSUs
|
Total Number
of RSAs
|
Total Number
of Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||||||||||
| Nonvested at December 31, 2020 |
|
|
|
$ |
|
|||||||||
| Granted |
|
|
|
|
||||||||||
| Vested |
(
|
(
|
(
|
|
||||||||||
| Forfeited |
(
|
|
(
|
|
||||||||||
| Nonvested at March 31, 2021 |
|
|
|
$ |
|
|||||||||
| FINANCIAL STATEMENTS | |||||
|
Total Number
of RSUs
|
Total Number
of RSAs
|
Total Number of Shares |
Weighted-Average
Grant Date
Fair Value
|
|||||||||||
| Nonvested at December 31, 2020 |
|
|
|
$ |
|
|||||||||
| Granted |
|
|
|
|
||||||||||
| Vested |
(
|
(
|
(
|
|
||||||||||
| Forfeited |
(
|
|
(
|
|
||||||||||
|
Nonvested at March 31, 2021
|
|
|
|
$ |
|
|||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2021 | 2020 | |||||||||||||||
| Cost of providing services | $ |
|
$ |
|
|||||||||||||
| Sales and marketing |
|
|
|||||||||||||||
| General and administrative |
|
|
|||||||||||||||
| Systems development and programming costs |
|
|
|||||||||||||||
| Total stock based compensation expense | $ |
|
$ |
|
|||||||||||||
|
Three Months Ended
March 31, |
|||||||||||||||||
| 2021 | 2020 | ||||||||||||||||
| Shares issued and outstanding, beginning balance |
|
|
|||||||||||||||
|
Issuance of common stock from vested restricted stock units
|
|
|
|||||||||||||||
|
Issuance of common stock from exercise of stock options
|
|
|
|||||||||||||||
|
Repurchase of common stock
|
(
|
(
|
|||||||||||||||
|
Awards effectively repurchased for required employee withholding taxes
|
(
|
(
|
|||||||||||||||
|
Shares issued and outstanding, ending balance
|
|
|
|||||||||||||||
| FINANCIAL STATEMENTS | |||||
|
Three Months Ended
March 31, |
|||||||||||||||||
| (in millions, except per share data) | 2021 | 2020 | |||||||||||||||
| Net income | $ |
|
$ |
|
|||||||||||||
| Weighted average shares of common stock outstanding |
|
|
|||||||||||||||
| Basic EPS | $ |
|
$ |
|
|||||||||||||
| Net income | $ |
|
$ |
|
|||||||||||||
| Weighted average shares of common stock outstanding |
|
|
|||||||||||||||
| Dilutive effect of stock options and restricted stock units |
|
|
|||||||||||||||
| Weighted average shares of common stock outstanding |
|
|
|||||||||||||||
| Diluted EPS | $ |
|
$ |
|
|||||||||||||
|
Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect
|
|
|
|||||||||||||||
| OTHER INFORMATION | |||||
| Period |
Total Number of
Shares
Purchased
(1)
|
Weighted Average Price
Paid Per Share |
Total Number of
Shares Purchased as Part of Publicly Announced Plans (2) |
Approximate Dollar Value ($ millions)
of Shares that May Yet be Purchased Under the Plans (3) |
|||||||||||||||||||||||||
| January 1- January 31, 2021 | 349,764 | $ | 80.78 | 335,791 | $ | 331 | |||||||||||||||||||||||
| February 1 - February 28, 2021 | 390,545 | $ | 80.97 | 338,735 | $ | 303 | |||||||||||||||||||||||
| March 1 - March 31, 2021 | 71,920 | $ | 81.59 | 69,475 | $ | 298 | |||||||||||||||||||||||
| Total | 812,229 | 744,001 | |||||||||||||||||||||||||||
| EXHIBITS | |||||
| Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||
| Exhibit No. | Exhibit | Form | File No. | Exhibit | Filing Date | Filed Herewith | ||||||||||||||||||||||||||||||||
| 3.1 | Amended and Restated Certificate of Incorporation of TriNet Group, Inc. | 8-K | 001-36373 | 3.1 | 4/1/2014 | |||||||||||||||||||||||||||||||||
| 3.2 | Certificate of Correction of Amended and Restated Certificate of Incorporation of TriNet Group, Inc. | 10-Q | 001-36373 | 3.1 | 11/2/2017 | |||||||||||||||||||||||||||||||||
| 3.2 | Amended and Restated Bylaws of TriNet Group, Inc. | S-1/A | 333-192465 | 3.4 | 3/4/2014 | |||||||||||||||||||||||||||||||||
| 4.1 | Registration Rights Agreement, by and between TriNet Group, Inc. and AGI-T, L.P., dated as of February 1, 2017. | 8-K | 001-36373 | 4.1 | 2/2/2017 | |||||||||||||||||||||||||||||||||
| 10.1 | Indenture dated February 26, 2021, among the Company, the guarantors listed therein and U.S. Bank National Association, as trustees | 8-K | 001-36373 | 4.1 | 2/26/2021 | |||||||||||||||||||||||||||||||||
| 10.2 | Form of 3.500% Senior Notes due 2029 (Included in Indenture, dated February 26, 2021) | 8-K | 001-36373 | 4.2 | 2/26/2021 | |||||||||||||||||||||||||||||||||
| 10.3 | Credit Agreement, dated as of February 26, 2021, among TriNet USA, Inc. as borrower, TriNet Group, Inc. as Holdings, the lenders from time-to-time party thereto and JP Morgan Chase Bank N.A., as Administrative Agent | 8-K | 001-36373 | 10.1 | 2/26/2021 | |||||||||||||||||||||||||||||||||
| 10.4 | X | |||||||||||||||||||||||||||||||||||||
| 10.5 | X | |||||||||||||||||||||||||||||||||||||
| 31.1 | X | |||||||||||||||||||||||||||||||||||||
| 31.2 | X | |||||||||||||||||||||||||||||||||||||
|
32.1*
|
X | |||||||||||||||||||||||||||||||||||||
|
101.INS
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|||||||||||||||||||||||||||||||||||||
| EXHIBITS | |||||
|
101.SCH
|
XBRL Taxonomy Extension Schema Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (embedded with the Inline XBRL document) | |||||||||||||||||||||||||||||||||||||
| * | Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of TriNet Group, Inc.’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing. | |||||||
| SIGNATURES | |||||
| TRINET GROUP, INC. | |||||||||||
| Date: April 26, 2021 | By: | /s/ Burton M. Goldfield | |||||||||
| Burton M. Goldfield | |||||||||||
| Chief Executive Officer | |||||||||||
| Date: April 26, 2021 | By: | /s/ Kelly Tuminelli | |||||||||
| Kelly Tuminelli | |||||||||||
| Chief Financial Officer | |||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|